Article info

Download PDFPDF

Original research
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study

Authors

  1. Correspondence to Dr Federico Diaz-Gonzalez; federico.diaz.gonzalez{at}gmail.com
View Full Text

Citation

Álvaro Gracia JM, Sanchez-Piedra C, Manero J on behalf of the COVIDSER study group, et al
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study

Publication history

  • Received September 9, 2021
  • Accepted November 9, 2021
  • First published December 9, 2021.
Online issue publication 
July 06, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.